MedPath

Liver Glycogen Dynamics

Not Applicable
Completed
Conditions
Hepatic Glycogen
Interventions
Behavioral: Overnight fasting duration
Registration Number
NCT04510155
Lead Sponsor
Maastricht University
Brief Summary

The purpose of this study is to investigate the effect of prolonged overnight fasting in the hepatic glycogen stores

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Participants are able to provide signed and dated written informed consent prior to any study specific procedures
  • Caucasian (people will be excluded when having a ≥50% racial African/Asian background)
  • Participants should have suitable veins for cannulation or repeated venipuncture
  • Women are post-menopausal (defined as at least 1 year post cessation of menses)
  • Men and women aged ≥ 45 and ≤ 75 years at the start of the study
  • Body mass index (BMI) 18.5 - 25 kg/m2
  • Stable dietary habits (no weight loss or gain >3kg in the past 3 months)
  • Sedentary lifestyle (not more than 3 hours of vigorous sports per week)
Exclusion Criteria
  • Type 2 Diabetes Mellitus
  • Active diseases (cardiovascular, diabetes, liver, kidney, cancer or other)
  • Any contraindication for MRI scanning
  • Alcohol consumption of >2 servings per day
  • Regular smoking
  • No use of medication interfering with investigated study parameters (as determined by responsible physician)
  • Participants who do not want to be informed about unexpected medical findings, or do not wish that their physician

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Long overnight fastOvernight fasting durationOvernight fasting duration intervention: Participants will receive their last evening meal at 4.30 pm and stay overnight fasted afterwards for (16h).
Short overnight fastOvernight fasting durationOvernight fasting duration intervention: Participants will receive their last evening meal at 11 pm and stay overnight fasted afterwards for (9.5h).
Primary Outcome Measures
NameTimeMethod
Hepatic glycogen content1 hour

Measured with 13C-MRS

Secondary Outcome Measures
NameTimeMethod
Substrate oxidation14 hours

Measured as RQ

Trial Locations

Locations (1)

Maastricht University

🇳🇱

Maastricht, Limburg, Netherlands

© Copyright 2025. All Rights Reserved by MedPath